Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

salicylic acid/inflamació

L'enllaç es desa al porta-retalls
Pàgina 1 des de 29 resultats

Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to unique formulations for treating inflammatory bowel disease (IBD), such as ulcerative colitis, including 5-amino salicylic acid (5ASA) and a phospholipid. The present invention relates to unique compositions of

Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
RELATED APPLICATIONS This application claims priority to U.S. patent application Ser. No. 11/880,059, entitled "PREPARATIONS OF PHOSPHOLIPIDS AND PHARMACEUTICALS CONTAINING 5-AMINO SALICYLIC ACID FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE," filed Jul. 19, 2007 now U.S. Pat. No. 7,700,651, which

Treatment of non-inflammatory and non-infectious bowel disorders

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD This invention relates to the production and use of therapeutic agents for the treatment of certain bowel disorders, namely disorders arising from unknown or non-obvious causes, which are unaccompanied by inflammation and are not due to detectable infection by known pathogenic

Inflammation-preventing pharmaceutical composition of oral administration

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE PRESENT INVENTION A great number of substances for the effective treatment of inflammatory illnesses, for example rheumatism, have been known for a long time. Since the inflammations are often chronic, the treatment with such inflammation-preventing active substances will usually

Inflammation-preventing pharmaceutical composition of oral administration

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE PRESENT INVENTION A great number of substances for the effective treatment of inflammatory illnesses, for example rheumatism, have been known for a long time. Since the inflammations are often chronic, the treatment with such inflammation-preventing active substances will usually

Inflammation-preventing pharmaceutical composition of oral administration

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE PRESENT INVENTION A great number of substances for the effective treatment of inflammatory illnesses, for example rheumatism, have been known for a long time. Since the inflammations are often chronic, the treatment with such inflammation-preventing active substances will usually

Inflammation-preventing pharmaceutical composition of oral administration

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE PRESENT INVENTION A great number of substances for the effective treatment of inflammatory illnesses, for example rheumatism, have been known for a long time. Since the inflammations are often chronic, the treatment with such inflammation-preventing active substances will usually

Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The present invention relates to a composition for oral consumption which, when taken orally can have benefits for the skin, and to the use of a combination of active compounds. Improving the appearance and feel of human skin has received a great deal of research effort. However, the vast majority

Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION The present invention relates to a group of novel pharmaceutically acceptable salts, each containing local anesthetic and anti-inflammatory activities. The preferred pharmaceutical acceptable salt in this group is diclofenac salt of lidocaine. Diclofenac is a non-steroidal

Analgesic and anti-inflammatory compositions for topical application

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION This invention relates to the use of salicylic acid derivatives. More particularly, it relates to compositions containing salicylic acid derivatives, and the topical use thereof on animals, including man, for providing an anti-inflammatory effect. Tissue inflammation is

Topical composition containing acetyl salicylic acid

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION The present invention relates to compositions and processes for relieving inflammation. More specifically, vehicles comprising monoolein and a diol having 3 or 4 carbon atoms are surprisingly effective carriers for the topical administration of acetylsalicylic

Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND Oxidative stress and inflammation are implicated in the pathogenesis of metabolic diseases, diabetes, obesity, dyslipidemia and their associated cardiovascular complications. For example, oxidative stress is a common pathogenic factor leading to insulin resistance, .beta.-cell

Compositions for skin exfoliation and use thereof

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION A variety of skin problems including acne, scars, pigmentation disorders, sun exposure, etc., have led to the development of a variety of compositions and therapies directed toward their treatment. Such treatments may include skin creams, lotions, or ointments which are

Polyprenyl compounds, process for the production thereof and medicines containing same

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The present invention relates to new polyprenyl compounds having excellent medicinal effects, processes for the production thereof and pharmaceutical compositions containing same. More particularly, the present invention relates to polyprenyl compounds of the general formula: ##STR1## wherein R

Methods of administering gaultherin-containing compositions

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE DISCLOSURE This disclosure relates to pharmaceutically active compounds obtained from natural sources. More specifically, the disclosure relates to methods of treating and preventing cancer, cardiovascular conditions, including cardiopulmonary conditions, and inflammatory responses by
Uneix-te a la nostra
pàgina de Facebook

La base de dades d’herbes medicinals més completa avalada per la ciència

  • Funciona en 55 idiomes
  • Cures a base d'herbes recolzades per la ciència
  • Reconeixement d’herbes per imatge
  • Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
  • Llegiu publicacions científiques relacionades amb la vostra cerca
  • Cerqueu herbes medicinals pels seus efectes
  • Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents

Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades

Google Play badgeApp Store badge